| eszopiclone / Generic mfg. |
NCT01710631: Twelve Month Study of the Safety of Eszopiclone in Adult Subjects With Insomnia |
|
|
| Completed | 3 | 791 | US | eszopiclone 3 mg, lunesta, placebo | Sunovion | Primary Insomnia | 08/02 | 08/02 | | |
NCT00352144: 6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia |
|
|
| Completed | 3 | 830 | US | Eszopiclone, Lunesta, S-Zopiclone, Placebo | Sunovion | Primary Insomnia | 10/04 | 10/04 | | |
NCT00368030: A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder |
|
|
| Completed | 3 | 545 | US | Eszopiclone, Lunesta, (S)-Zopliclone, Placebo | Sunovion | Insomnia, Depressive Disorder, Major | 10/04 | 10/04 | | |
NCT00367965: Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis |
|
|
| Completed | 3 | 153 | US | Eszopiclone, Lunesta, S-zopiclone, placebo | Sunovion | Insomnia, Arthritis, Rheumatoid | 11/04 | 11/04 | | |
NCT00366093: Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause |
|
|
| Completed | 3 | 410 | US | Eszopiclone, Lunesta, S-zopiclone, Placebo | Sunovion | Insomnia | 01/05 | 01/05 | | |
| Completed | 3 | 32 | Europe | Eszopiclone, S-Zopiclone, Lunesta, Placebo | Sunovion | Primary Insomnia | 06/06 | 06/06 | | |
NCT00324896: Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone |
|
|
| Completed | 3 | 30 | US | eszopiclone, Lunesta 2 - 3 mg q HS, placebo | University of Medicine and Dentistry of New Jersey, Sunovion | Parkinson's Disease, Insomnia | 06/09 | 06/09 | | |
| Completed | 3 | 678 | Europe, RoW | Eszopiclone, Lunesta, Placebo, Venlafaxine, Effexor | Sunovion | Major Depressive Disorder, Insomnia | 07/09 | 07/09 | | |
NCT00770692: A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150) |
|
|
| Completed | 3 | 369 | Japan | Eszopiclone 1 mg- Elderly, SEP-190, Eszopiclone 2 mg- Elderly, Eszopiclone 3 mg- Non-elderly, Eszopiclone 2 mg- Non-elderly | Eisai Co., Ltd. | Insomnia | 05/10 | 05/10 | | |
NCT00856973: Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia |
|
|
| Completed | 3 | 486 | US | eszopiclone, Placebo | Sunovion | Insomnia, Attention Deficit Hyperactivity Disorder | 07/11 | 07/11 | | |
NCT00857220: Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia |
|
|
| Completed | 3 | 304 | US | eszopiclone | Sunovion | Insomnia, Attention Deficit Hyperactivity Disorder | 10/11 | 10/11 | | |
Eszo, NCT01100164: A Non-inferiority Study With Two Treatment Arms piclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia |
|
|
| Completed | 3 | 263 | RoW | Eszopiclone, Zopiclone | Eurofarma Laboratorios S.A. | INSOMNIA | 03/12 | 04/12 | | |
| Recruiting | 3 | 774 | US | Trazodone, Eszopiclone, Placebo | VA Office of Research and Development | Insomnia | 02/26 | 02/26 | | |
| Completed | 2/3 | 30 | US | Mindfulness-Based Stress Reduction, eszopiclone, LUNESTA® | University of Minnesota, Hennepin County Medical Center, Minneapolis | Chronic Insomnia, Primary Insomnia | 06/09 | 06/09 | | |
NCT00770510: A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126) |
|
|
| Completed | 2/3 | 192 | Japan | Eszopiclone 1 mg, SEP-190, Eszopiclone 2 mg, Eszopiclone 3 mg, Placebo, Zolpidem Tartrate 10 mg | Eisai Co., Ltd. | Primary Insomnia | 05/10 | 05/10 | | |
